148 related articles for article (PubMed ID: 24636145)
1. CD14(+) HLA-DR low/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma.
Khalifa KA; Badawy HM; Radwan WM; Shehata MA; Bassuoni MA
Int J Lab Hematol; 2014 Dec; 36(6):650-5. PubMed ID: 24636145
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.
Lin Y; Gustafson MP; Bulur PA; Gastineau DA; Witzig TE; Dietz AB
Blood; 2011 Jan; 117(3):872-81. PubMed ID: 21063024
[TBL] [Abstract][Full Text] [Related]
3. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
[TBL] [Abstract][Full Text] [Related]
4. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
[TBL] [Abstract][Full Text] [Related]
5. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
[No Abstract] [Full Text] [Related]
6. Increases in inflammatory and CD14
Gainaru G; Papadopoulos A; Tsangaris I; Lada M; Giamarellos-Bourboulis EJ; Pistiki A
Crit Care; 2018 Mar; 22(1):56. PubMed ID: 29499723
[TBL] [Abstract][Full Text] [Related]
7. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive monocytes (CD14
Lima DS; Lemes RPG; Matos DM
Med Oncol; 2018 Feb; 35(3):36. PubMed ID: 29429058
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
Vuk-Pavlović S; Bulur PA; Lin Y; Qin R; Szumlanski CL; Zhao X; Dietz AB
Prostate; 2010 Mar; 70(4):443-55. PubMed ID: 19902470
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of tissue factor and vascular endothelial growth factor expressions on CD14+ monocytes in patients with non Hodgkin lymphoma].
Wang HX; Li XM; Han XH; Jiang YJ; Zhu GH; Zhuang WC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):427-31. PubMed ID: 21906453
[TBL] [Abstract][Full Text] [Related]
11. Rapid flow cytometric identification of putative CD14- and CD64- dendritic cells in whole blood.
Macey MG; McCarthy DA; Vogiatzi D; Brown KA; Newland AC
Cytometry; 1998 Mar; 31(3):199-207. PubMed ID: 9515719
[TBL] [Abstract][Full Text] [Related]
12. Expanded CD14
Zhang R; Shi J; Zhang R; Ni J; Habtezion A; Wang X; Hu G; Xue J
J Immunol; 2019 May; 202(9):2578-2584. PubMed ID: 30894427
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
Yuan XK; Zhao XK; Xia YC; Zhu X; Xiao P
J Int Med Res; 2011; 39(4):1381-91. PubMed ID: 21986138
[TBL] [Abstract][Full Text] [Related]
14. Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia.
Wang Z; Yang L; Ye J; Wang Y; Liu Y
Immunol Res; 2019 Oct; 67(4-5):373-381. PubMed ID: 31773491
[TBL] [Abstract][Full Text] [Related]
15. Circulating CD14(+)HLA-DR(-/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC.
Huang H; Zhang G; Li G; Ma H; Zhang X
Tumour Biol; 2015 Sep; 36(10):7987-96. PubMed ID: 25967454
[TBL] [Abstract][Full Text] [Related]
16. [Study on monocyte HLA-DR expression in critically ill patients after surgery].
Zhang YT; Fang Q
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1480-2. PubMed ID: 17349175
[TBL] [Abstract][Full Text] [Related]
17. CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.
Speigl L; Burow H; Bailur JK; Janssen N; Walter CB; Pawelec G; Shipp C
Breast Cancer Res Treat; 2018 Apr; 168(2):401-411. PubMed ID: 29230664
[TBL] [Abstract][Full Text] [Related]
18. Immunoparalysis: Clinical and immunological associations in SIRS and severe sepsis patients.
Papadopoulos P; Pistiki A; Theodorakopoulou M; Christodoulopoulou T; Damoraki G; Goukos D; Briassouli E; Dimopoulou I; Armaganidis A; Nanas S; Briassoulis G; Tsiodras S
Cytokine; 2017 Apr; 92():83-92. PubMed ID: 28119177
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients.
Kowalska W
Folia Histochem Cytobiol; 2020; 58(1):17-24. PubMed ID: 32176313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
